COVID-19
Conditions
Interventions
None listed
Sponsors
Fukuoka City Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Employees of Fukuoka City Hospital who have been measured spike-specific antibody titers and interferon gamma levels.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in spike-specific antibody titers and interferon gamma levels one month after an Omicron BA.4/BA.5-Adapted Bivalent Booster. | — |
Secondary
| Measure | Time frame |
|---|---|
| The relation between the degree of adverse reactions and the strength of the immune response to an Omicron BA.4/BA.5-Adapted Bivalent Booster. | — |
Countries
Japan
Contacts
Public ContactNaoki Tani
Kyushu University Graduate School of Medical Sciences Medicine and Biosystemic Science
Outcome results
None listed